Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-23T11:17:37.270Z Has data issue: false hasContentIssue false
  • English
  • Français

Transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2

Published online by Cambridge University Press:  13 December 2017

Li-Jian Zhao ,
Bo Han ,
Jian-Jun Zhang ,
Ying-Chun Yi ,
Dian-Dong Jiang  and
Jian-Li Lyu
Li-Jian Zhao
Affiliation:
Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
Bo Han*
Affiliation:
Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
Jian-Jun Zhang
Affiliation:
Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
Ying-Chun Yi
Affiliation:
Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
Dian-Dong Jiang
Affiliation:
Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
Jian-Li Lyu
Affiliation:
Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
*
Correspondence to: Dr B. Han, Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China. Tel: 13605313927; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

The objective of this study was to explore the clinical effect of the transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2.

Methods

Between February 2012 and December 2016, 51 patients were subjected to Amplatzer duct occluder 2 for transcatheter closure of perimembranous ventricular septal defect. A total of 51 patients with perimembranous ventricular septal defect who underwent transcatheter closure by the conventional membranous ventricular septal occluder comprised the control group. The success rate and complications were compared, and indications of Amplatzer duct occluder 2 for perimembranous ventricular septal defect were explored.

Results

The success rate of the interventional procedure was 98.0% (50/51) in the group of Amplatzer duct occluder 2 versus 100% in the group of conventional membranous ventricular septal occluder. The mean age of the patients of Amplatzer duct occluder group was 5.0±3.7 years (range: 1.5–25.0), and the mean weight was 19.3±8.1 kg (range: 11.0–52.0). The mean outlet diameter of the defects was 2.8±0.6 mm (range: 1.8–5.1) as measured by transthoracic echocardiography. The device was implanted by a retrograde approach in 40 patients and antegrade approach in 10 patients. No statistical significance was observed in the incidence of complication and hospitalisation duration between the two groups; however, the Amplatzer duct occluder 2 group was cost-effective (p<0.05) and required less fluoroscopy time (p<0.05). Neither deaths nor new onset of aortic and tricuspid insufficiency occurred during the median 26.2 months (range: 3–65) of follow-up.

Conclusions

Amplatzer duct occluder 2 has advantages of simple manipulation and less medical costs compared with conventional device in transcatheter closure of small type perimembranous ventricular septal defect.

Keywords

Ventricular septal defecttranscatheter closureoccluderinterventional procedurecomplication
Type
Original Articles
Information
Cardiology in the Young , Volume 28 , Issue 3 , March 2018 , pp. 447 - 453
Check for updates
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Hoffman, JI. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995; 16: 103–113.Google Scholar
2. Hoffman, JI, Kaplan, S, Liberthson, RR. Prevalence of congenital heart disease. Am Heart J 2004; 147: 425–439.Google Scholar
3. Saurav, A, Kaushik, M, Mahesh Alla, V, et al. Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2015; 86: 1048–1056.Google Scholar
4. Bai, Y, Liu, J, Qin, YW, Wu, H, Zhao, XX. Percutaneous closure of perimembranous ventricular septal defect with modified double-disk occluder: what Is the outcome at 10-year follow-up? Congenit Heart Dis 2015; 11: 45–51.Google Scholar
5. Yang, J, Yang, L, Yu, S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol 2014; 63: 1159–1168.Google Scholar
6. El-Sisi, A, Sobhy, R, Jaccoub, V, Hamza, H. Perimembranous ventricular septal defect device closure: choosing between amplatzer duct occluder I and II. Pediatric Cardiol 2017; 38: 596–602.Google Scholar
7. Zhao, PJ, Yu, ZQ, Gao, W, et al. Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II. Zhonghua Xin Xue Guan Bing Za Zhi 2012; 40: 817–820.Google ScholarPubMed
8. Koneti, NR, Penumatsa, RR, Kanchi, V, et al. Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II. Catheter Cardiovasc Interv 2011; 77: 252–259.Google Scholar
9. Polat, TB, Turkmen, E. Transcatheter closure of ventricular septal defects using the Amplatzer Duct Occluder II device: a single-center experience. Postepy Kardiol Interwencyjnej 2016; 12: 340–347.Google Scholar
10. Zuo, J, Xie, J, Yi, W, et al. Results of transcatheter closure of perimembranous ventricular septal defect. Am J Cardiol 2010; 106: 1034–1037.CrossRefGoogle ScholarPubMed
11. Zhou, T, Shen, XQ, Zhou, SH, et al. Atrioventricular block: a serious complication in and after transcatheter closure of perimembranous ventricular septal defects. Clin Cardiol 2008; 31: 368–371.CrossRefGoogle ScholarPubMed
12. Zhou, D, Pan, W, Guan, L, Ge, J. Transcatheter closure of perimembranous and intracristal ventricular septal defects with the SHSMA occluder. Catheter Cardiovasc Interv 2012; 79: 666–674.Google Scholar
13. Yang, L, Tai, BC, Khin, LW, Quek, SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Interv Cardiol 2014; 27: 260–272.Google Scholar
14. Kanaan, M, Ewert, P, Berger, F, Assa, S, Schubert, S. Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer duct occluder II. Pediatr Cardiol 2015; 36: 379–385.Google Scholar